Similar articles

• Levosimendan in patients with low-output heart failure: lessons from the LIDO trial.

  Follath F. Follath F. Ital Heart J. 2003 May;4 Suppl 2:34S-38S. Ital Heart J. 2003. PMID: 14635368 Clinical Trial.
• [Levosimendan for treatment of heart failure].

  Yasumura Y. Yasumura Y. Nihon Rinsho. 2007 May 28;65 Suppl 5:169-72. Nihon Rinsho. 2007. PMID: 17571380 Review. Japanese. No abstract available.
• Is calcium sensitization the best strategy to improve myocardial contractility in acute heart failure?

  Erhardt LR. Erhardt LR. Ital Heart J. 2003 May;4 Suppl 2:27S-33S. Ital Heart J. 2003. PMID: 14635367 Review.
• [Calcium mobilizers and calcium sensitizers].

  Arai M. Arai M. Nihon Rinsho. 2011 Nov;69 Suppl 9:417-22. Nihon Rinsho. 2011. PMID: 22724240 Review. Japanese. No abstract available.
• Mechanisms of a reduced cardiac output and the effects of milrinone and levosimendan in a model of infant cardiopulmonary bypass.

  Stocker CF, Shekerdemian LS, Nørgaard MA, Brizard CP, Mynard JP, Horton SB, Penny DJ. Stocker CF, et al. Crit Care Med. 2007 Jan;35(1):252-9. doi: 10.1097/01.CCM.0000251123.70632.4E. Crit Care Med. 2007. PMID: 17133188